| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRSL.2018.12.002 |
| P698 | PubMed publication ID | 30615845 |
| P50 | author | Sandra Morales | Q91164279 |
| Alkis J Psaltis | Q80550747 | ||
| P2093 | author name string | Peter-John Wormald | |
| Sarah Vreugde | |||
| John W Finnie | |||
| Sathish Paramasivan | |||
| Mian Li Ooi | |||
| Amanda J Drilling | |||
| Stephanie A Fong | |||
| P2860 | cites work | A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy | Q22061813 |
| Bacteriophage therapy | Q24550616 | ||
| Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections | Q26823401 | ||
| Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration | Q28484466 | ||
| Quantification of biofilm structures by the novel computer program comstat | Q28547921 | ||
| The biofilm matrix | Q29547334 | ||
| Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis | Q83706542 | ||
| EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists | Q83792713 | ||
| Bacterial biofilms in chronic rhinosinusitis and their relationship with inflammation severity | Q84274195 | ||
| Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial | Q84565387 | ||
| In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage | Q84742668 | ||
| The bacteriology of chronic rhinosinusitis and the pre-eminence of Staphylococcus aureus in revision patients | Q86299608 | ||
| Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012 | Q87444358 | ||
| Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis | Q33289454 | ||
| A sheep model for the study of biofilms in rhinosinusitis | Q33290402 | ||
| An in vitro model of Pseudomonas aeruginosa biofilms on viable airway epithelial cell monolayers | Q33347644 | ||
| Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. | Q33509952 | ||
| Phage neutralization by sera of patients receiving phage therapy | Q33828266 | ||
| Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention | Q33828309 | ||
| Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample | Q33872652 | ||
| Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy | Q33883731 | ||
| Quantitative analysis of in vivo mucosal bacterial biofilms | Q34152474 | ||
| Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis | Q34531349 | ||
| Bacteriophages: an appraisal of their role in the treatment of bacterial infections | Q34637115 | ||
| Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. | Q34790316 | ||
| Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities | Q35535822 | ||
| Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm | Q35634231 | ||
| Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells | Q35827006 | ||
| The bacterial microbiome in chronic rhinosinusitis: Richness, diversity, postoperative changes, and patient outcomes | Q35921109 | ||
| Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays | Q36076253 | ||
| Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities | Q36156448 | ||
| Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population | Q36446023 | ||
| A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions | Q36483482 | ||
| National burden of antibiotic use for adult rhinosinusitis | Q37274979 | ||
| Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis | Q37397934 | ||
| Different biofilms, different disease? A clinical outcomes study | Q37773865 | ||
| Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. | Q38123588 | ||
| Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH). | Q40816973 | ||
| An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis | Q41112387 | ||
| The multifaceted roles of antibiotics and antibiotic resistance in nature | Q41249257 | ||
| Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol | Q41275723 | ||
| Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients | Q41919523 | ||
| Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities | Q42103948 | ||
| Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis | Q42241966 | ||
| The Economic Burden and Symptom Manifestations of Chronic Rhinosinusitis | Q44136994 | ||
| Evidence of bacterial biofilms in a rabbit model of sinusitis. | Q52563412 | ||
| Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. | Q53153166 | ||
| CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. | Q53195491 | ||
| Electron Microscopy Assessment of the Recovery of Sinus Mucosa after Sinus Surgery | Q58190053 | ||
| Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms | Q60649764 | ||
| Economic implications of chronic sinusitis | Q74397820 | ||
| Tissue eosinophilia in chronic sinusitis: quantification techniques | Q74512531 | ||
| P921 | main subject | phage therapy | Q611870 |
| Pseudomonas aeruginosa | Q31856 | ||
| bacteriophage | Q165028 | ||
| P304 | page(s) | 41-56 | |
| P577 | publication date | 2018-12-19 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis | |
| P478 | volume | 206 |
Search more.